<bill session="119" type="s" number="705" updated="2025-07-24T14:25:08Z">
  <state datetime="2025-02-25">REFERRED</state>
  <status>
    <introduced datetime="2025-02-25"/>
  </status>
  <introduced datetime="2025-02-25"/>
  <titles>
    <title type="display">Innovation in Pediatric Drugs Act of 2025</title>
    <title type="short" as="introduced">Innovation in Pediatric Drugs Act of 2025</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="R000122"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2025-02-25"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2025-02-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S1347" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
</bill>
